Published in Pharm Res on January 01, 1998
Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect (2003) 1.87
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin. J Control Release (2010) 1.00
Skin models for the testing of transdermal drugs. Clin Pharmacol (2016) 0.75
Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection. BMC Dermatol (2009) 0.75
Effect of Frozen Human Epidermis Storage Duration and Cryoprotectant on Barrier Function Using Two Model Compounds. Skin Pharmacol Physiol (2015) 0.75
Tissue recovery practices and bioburden: a systematic review. Cell Tissue Bank (2016) 0.75
Absorption of some organic compounds through the skin in man. J Invest Dermatol (1970) 2.70
Percutaneous penetration of some pesticides and herbicides in man. Toxicol Appl Pharmacol (1974) 2.27
How irritant is alcohol? Br J Dermatol (2007) 1.78
Regional variation in percutaneous penetration in man. Pesticides. Arch Environ Health (1971) 1.76
Textile dye dermatitis. J Am Acad Dermatol (1995) 1.76
Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol (1967) 1.75
Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells. J Infect Dis (1980) 1.72
Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol (2006) 1.67
Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. J Invest Dermatol (1998) 1.63
Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci (2008) 1.55
Current concepts in parasitology. This scabies pandemic. N Engl J Med (1978) 1.54
Contact dermatitis in the atopic. Acta Derm Venereol (1970) 1.53
North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol (1998) 1.51
Treatment of today's scabies and pediculosis. JAMA (1976) 1.51
Microbial flora of atopic dermatitis. Arch Dermatol (1977) 1.51
Influence of area of application of allergen on sensitization in contact dermatitis. Contact Dermatitis (1992) 1.50
Surfactants and experimental irritant contact dermatitis. Contact Dermatitis (1995) 1.49
Competitive adherence as a mechanism of bacterial interference. Can J Microbiol (1983) 1.48
Differential irritant skin responses to tandem application of topical retinoic acid and sodium lauryl sulphate: II. Effect of time between first and second exposure. Br J Dermatol (1997) 1.42
Photocontact dermatitis to halogenated salicylanilides and related compounds. A clinical and histological review of 26 patients. Arch Dermatol (1968) 1.41
Monitoring the European standard series in 10 centres 1996-2000. Contact Dermatitis (2005) 1.41
[The maternal-neonatal characteristics of intrauterine growth retardation in a term pregnancy based on a national curve of intrauterine growth]. Rev Chil Obstet Ginecol (1991) 1.39
Topical iontophoretic drug delivery in vivo: historical development, devices and future perspectives. Dermatology (1993) 1.39
Patterns of hyaluronan staining are modified by fixation techniques. J Histochem Cytochem (1997) 1.36
Occupational dermatitis in five European dermatological departments. Berufsdermatosen (1971) 1.35
Effects of a systemic antibiotic on nasal bacterial ecology in man. Appl Microbiol (1970) 1.34
Cell renewal in human epidermis. Arch Dermatol (1965) 1.33
The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations--an overview. Skin Pharmacol Appl Skin Physiol (2000) 1.32
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. Pharm Res (1998) 1.31
Bacterial interference among strains of Staphylococcus aureus in man. J Infect Dis (1974) 1.31
Bacterial adherence to nasal mucosal cells. Infect Immun (1977) 1.29
The inhibitory effect of antiallergy drugs on allergen and histamine induced wheal and flare response. J Allergy Clin Immunol (1973) 1.27
Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response? N Engl J Med (1971) 1.24
Allergic contact dermatitis. Arch Dermatol (1968) 1.23
Comparative study on the antimicrobial effect of 0.5% chlorhexidine gluconate and 70% isopropyl alcohol on the normal flora of hands. Appl Environ Microbiol (1979) 1.23
Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol (2007) 1.22
Correlation of human in vivo and in vitro cutaneous antimicrobial factors. J Infect Dis (1975) 1.21
In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Pharm Res (1998) 1.20
Elastic properties of human skin: relation to age, sex, and anatomical region. Arch Dermatol Res (1990) 1.20
Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J Invest Dermatol (1991) 1.19
Candida and candidiasis. 1. Cultural conditions, epidemiology and pathogenesis. Postgrad Med (1973) 1.19
The use of graded concentrations in studying skin sensitizers: experimental contact sensitization in man. Food Cosmet Toxicol (1974) 1.16
Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol (1978) 1.15
Survival of pathogenic microorganisms on human skin. J Invest Dermatol (1972) 1.15
Surface coats containing polysaccharides on human epidermal cells. J Invest Dermatol (1968) 1.14
The contact urticaria syndrome--an updated review. J Am Acad Dermatol (1981) 1.13
Skin permeability in vivo: comparison in rat, rabbit, pig and man. J Invest Dermatol (1972) 1.13
Measurement of the transit time for cells through the epidermis and stratum corneum of the mouse and guinea-pig. Cell Tissue Kinet (1987) 1.13
How irritant is water? An overview. Contact Dermatitis (1999) 1.11
The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol (1971) 1.10
Frequency of application of topical corticosteroids: an overview. Br J Dermatol (1998) 1.09
Reproducibility of allergy epicutaneous test techniques. J Allergy Clin Immunol (1973) 1.09
Candida and candidiasis. 2. Clinical manifestations and therapy of candidal disease. Postgrad Med (1973) 1.08
Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol (1988) 1.08
A comparison of rabbit and human skin response to certain irritants. Toxicol Appl Pharmacol (1972) 1.08
The role of vehicles in diagnostic patch testing. A reappraisal. Contact Dermatitis (1993) 1.08
A five-year study of cosmetic reactions. J Am Acad Dermatol (1985) 1.08
Importance of the keratinized epithelial cell in bacterial adherence. J Invest Dermatol (1982) 1.08
Aerobic microbial flora of intertrigenous skin. Appl Environ Microbiol (1977) 1.07
Estrogen and skin. An overview. Am J Clin Dermatol (2001) 1.07
Hyaluronic acid and skin: wound healing and aging. Int J Dermatol (1996) 1.06
An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis. Contact Dermatitis (2000) 1.06
Drug release from a suspension with a finite dissolution rate: theory and its application to a betamethasone 17-valerate patch. J Pharm Sci (1994) 1.05
HPLC-accelerator MS measurement of atrazine metabolites in human urine after dermal exposure. Anal Chem (1999) 1.05
Methotrexate for psoriasis. Arch Dermatol (1967) 1.05
Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Skin Physiol (2001) 1.05
Methotrexate guidelines--revised. J Am Acad Dermatol (1982) 1.04
Percutaneous penetration of steroids in man. J Invest Dermatol (1969) 1.04
Bacterial interference treatment of recurrent furunculosis. 2. Demonstration of the relationship of strain to pathogeneicity. JAMA (1969) 1.04
Use of methotrexate in psoriasis. Arch Dermatol (1972) 1.04
Immediate hypersensitivity to seminal fluid and atopic dermatitis. Arch Dermatol (1980) 1.03
Percutaneous penetration and disposition of triclocarban in man: body showering. Arch Environ Health (1975) 1.03
Vitamin B1 is not a systemic mosquito repellent in man. Trans St Johns Hosp Dermatol Soc (1969) 1.03
In vivo percutaneous absorption and decontamination of pesticides in humans. J Toxicol Environ Health (1985) 1.03
Skin aging. Effect on transepidermal water loss, stratum corneum hydration, skin surface pH, and casual sebum content. Arch Dermatol (1991) 1.03
Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol (1984) 1.02
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci (2011) 1.02
In vivo biophysical characterization of skin physiological differences in races. Dermatologica (1991) 1.01
Modern aspects of scabies. Curr Probl Dermatol (1985) 1.01
Bacterial interference: relating to chronic furunculosis in man. Br J Dermatol (1969) 1.01
Letter: Presumed generalized exfoliative dermatitis to lidocaine. Arch Dermatol (1975) 1.00
Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol (2005) 1.00
Noninvasive assessment of local nicotinate pharmacodynamics by photoplethysmography. J Invest Dermatol (1983) 1.00
Detection of environmental depigmenting substances. Contact Dermatitis (1979) 1.00
Glutathione as a depigmenting agent: an overview. Int J Cosmet Sci (2005) 0.99
Colorimetric method for quantifying human Stratum corneum removed by adhesive-tape stripping. Acta Derm Venereol (1998) 0.99
Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metab Rev (1983) 0.99
The effect of DMSO on percutaneous penetration of hydrocortisone and testosterone in man. Ann N Y Acad Sci (1967) 0.98
Relationship between systemic corticosteroids and osteonecrosis. Am J Clin Dermatol (2001) 0.98
In vivo percutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers. J Am Acad Dermatol (1983) 0.98
In vivo percutaneous absorption of paraquat from hand, leg, and forearm of humans. J Toxicol Environ Health (1984) 0.98
Drugs and disease as mosquito repellents in man. Am J Trop Med Hyg (1968) 0.97
Glyphosate skin binding, absorption, residual tissue distribution, and skin decontamination. Fundam Appl Toxicol (1991) 0.97
Staphylococcus aureus carriage in twins. Am J Dis Child (1974) 0.97
Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine. Anal Chem (1998) 0.97
Prevalence and relevance of allergic reactions in patients patch tested in North America--1984 to 1985. J Am Acad Dermatol (1989) 0.96
A comparison of the antimicrobial effect of 0.5% chlorhexidine (Hibistat) and 70% isopropyl alcohol on hands contaminated with Serratia marcescens. Clin Exp Dermatol (1980) 0.96
Percutaneous absorption of drugs. Clin Pharmacokinet (1992) 0.96
Mouse retina explants after long-term culture in serum free medium. J Chem Neuroanat (2001) 0.96